InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the complete record of transactions filed by Truong Vu. Officer active across 1 company, notably Aridis Pharmaceuticals, Inc.. In total, 3 disclosures have been recorded. Split: 2 buys · 0 sell. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Truong Vu is CEO at Aridis Pharmaceuticals, Inc. (XNAS). He has 4 filings in total, and across the 4 sampled recent filings the transactions are acquisitions, with EUR 89807 of purchases and EUR 0 of sales between 2021-07-27 and 2024-06-28.